Previous Close | 42.20 |
Open | 42.20 |
Bid | 48.50 |
Ask | 51.50 |
Strike | 165.00 |
Expire Date | 2024-07-19 |
Day's Range | 42.20 - 42.20 |
Contract Range | N/A |
Volume | |
Open Interest | 7 |
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.